Synthesis of triazolylmethyl-linked nucleoside analogs via combination of azidofuranoses with propargylated nucleobases and study on their cytotoxicity
dc.contributor.author | Halay E. | |
dc.contributor.author | Ay E. | |
dc.contributor.author | Şalva E. | |
dc.contributor.author | Ay K. | |
dc.contributor.author | Karayıldırım T. | |
dc.date.accessioned | 2024-07-22T08:10:01Z | |
dc.date.available | 2024-07-22T08:10:01Z | |
dc.date.issued | 2018 | |
dc.description.abstract | [Figure not available: see fulltext.] Copper(I)-catalyzed azide–alkyne 1,3-dipolar cycloaddition reactions (CuAAC) between azidofuranoses and propargyl-nucleobases were carried out in the presence of CuSO4·5H2O and sodium ascorbate as catalytic system to provide the corresponding 1,4-disubstituted-1,2,3-triazole-bridged nucleoside analogs in good yields. Twelve new sugar-based triazolylmethyl-linked nucleoside analogs were synthesized and screened for their cytotoxic activity against MDA-MB-231, Hep3B, PC-3, SH-SY5Y, and HCT-116 cancer cell lines and control cell line (L929). Most of the compounds were moderately effective against all the cancer cell lines assayed. Particularly, among the tested compounds, 1,2,3-triazole-linked 5-fluorouracil–mannofuranose hybrid was found to be the most potent cytotoxic agent against HCT-116, Hep3B, SH-SY5Y cells with IC50 values of 35.6, 71.1, and 75.6 μM, respectively. None of the triazolylmethyl-linked nucleoside analogs exhibited cytotoxic effect against the control cells L929. © 2018, Springer Science+Business Media, LLC, part of Springer Nature. | |
dc.identifier.DOI-ID | 10.1007/s10593-018-2248-4 | |
dc.identifier.issn | 00093122 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15054 | |
dc.language.iso | English | |
dc.publisher | Springer New York LLC | |
dc.title | Synthesis of triazolylmethyl-linked nucleoside analogs via combination of azidofuranoses with propargylated nucleobases and study on their cytotoxicity | |
dc.type | Article |